Literature DB >> 17991437

Identification and characterization of follistatin as a novel angiogenin-binding protein.

Xiangwei Gao1, Huajun Hu, Junqiao Zhu, Zhengping Xu.   

Abstract

Angiogenin enhances tumorigenesis. However, the mechanisms of angiogenin-induced angiogenesis and cancer cell proliferation remain elusive. In this study, follistatin was identified as a binding partner of angiogenin by a yeast two-hybrid screen and confirmed by a pull-down experiment. The interaction of fluorescently tagged angiogenin and follistatin was monitored in real time by a laser confocal microscope and shown to localize at the sub-nuclear region of HeLa cells. Additional yeast two-hybrid analysis revealed that domains 2 and 3 of follistatin were the minimal structure requirement for angiogenin binding. These findings provide new clues for further studies on the mechanisms of angiogenin-induced angiogenesis or cancer cell growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991437     DOI: 10.1016/j.febslet.2007.10.059

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

Review 1.  Physical activity and its mechanistic effects on prostate cancer.

Authors:  A Wekesa; M Harrison; R W Watson
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-03-24       Impact factor: 5.554

Review 2.  New insights into the role of angiogenin in actin polymerization.

Authors:  Mikhail G Pyatibratov; Alla S Kostyukova
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

3.  Serum follistatin in patients with prostate cancer metastatic to the bone.

Authors:  Francesca Maria Tumminello; Giuseppe Badalamenti; Fabio Fulfaro; Lorena Incorvaia; Marilena Crescimanno; Carla Flandina; Maria Vittoria Sepporta; Gaetano Leto
Journal:  Clin Exp Metastasis       Date:  2010-07-11       Impact factor: 5.150

4.  Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis.

Authors:  Jinhong Zhu; Yong Li; Aiping Lu; Burhan Gharaibeh; Jianqun Ma; Tetsuo Kobayashi; Andres J Quintero; Johnny Huard
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

5.  Activins and follistatins: Emerging roles in liver physiology and cancer.

Authors:  Emanuel Kreidl; Deniz Oztürk; Thomas Metzner; Walter Berger; Michael Grusch
Journal:  World J Hepatol       Date:  2009-10-31

6.  Nucleolar follistatin promotes cancer cell survival under glucose-deprived conditions through inhibiting cellular rRNA synthesis.

Authors:  Xiangwei Gao; Saisai Wei; Kairan Lai; Jinghao Sheng; Jinfeng Su; Junqiao Zhu; Haojie Dong; Hu Hu; Zhengping Xu
Journal:  J Biol Chem       Date:  2010-09-15       Impact factor: 5.157

7.  Angiogenin Prevents Progranulin A9D Mutation-Induced Neuronal-Like Cell Apoptosis Through Cleaving tRNAs into tiRNAs.

Authors:  Siqi Li; Yongdui Chen; Desen Sun; Rongpai Bai; Xiangwei Gao; Yi Yang; Jinghao Sheng; Zhengping Xu
Journal:  Mol Neurobiol       Date:  2017-01-27       Impact factor: 5.590

Review 8.  Follistatin as potential therapeutic target in prostate cancer.

Authors:  Maria Vittoria Sepporta; Francesca Maria Tumminello; Carla Flandina; Marilena Crescimanno; Marco Giammanco; Maurizio La Guardia; Danila di Majo; Gaetano Leto
Journal:  Target Oncol       Date:  2013-03-01       Impact factor: 4.493

Review 9.  Three decades of research on angiogenin: a review and perspective.

Authors:  Jinghao Sheng; Zhengping Xu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-12-23       Impact factor: 3.848

10.  Binding of human angiogenin inhibits actin polymerization.

Authors:  Mikhail G Pyatibratov; Dmitri Tolkatchev; Josee Plamondon; Ping Xu; Feng Ni; Alla S Kostyukova
Journal:  Arch Biochem Biophys       Date:  2010-01-04       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.